These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15252773)

  • 21. Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
    Elbassuoni EA; Aziz NM; El-Tahawy NF
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):617-624. PubMed ID: 29351386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The renal endothelium in diabetic nephropathy.
    Eleftheriadis T; Antoniadi G; Pissas G; Liakopoulos V; Stefanidis I
    Ren Fail; 2013; 35(4):592-9. PubMed ID: 23472883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
    Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
    Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of nitric oxide in reflux nephropathy.
    Chertin B; Rolle U; Farkas A; Puri P
    Pediatr Surg Int; 2002 Oct; 18(7):630-4. PubMed ID: 12471480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide synthase gene polymorphisms and diabetic nephropathy.
    Rippin JD; Patel A; Belyaev ND; Gill GV; Barnett AH; Bain SC
    Diabetologia; 2003 Mar; 46(3):426-8. PubMed ID: 12687343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial nitric oxide synthase.
    Nakagawa T; Johnson RJ
    Contrib Nephrol; 2011; 170():93-101. PubMed ID: 21659762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat.
    Akingba AG; Burnett AL
    Mol Urol; 2001; 5(4):189-97. PubMed ID: 11790282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of impaired vascular reactivity in a rat model of diabetic nephropathy: effect of nitric oxide synthesis inhibition on intrarenal diffusion and oxygenation measured by magnetic resonance imaging.
    Hueper K; Hartung D; Gutberlet M; Gueler F; Sann H; Husen B; Wacker F; Reiche D
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1428-35. PubMed ID: 24005471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D; Schwartz IF; Blantz RC
    J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide.
    Goligorsky MS; Chen J; Brodsky S
    Hypertension; 2001 Feb; 37(2 Pt 2):744-8. PubMed ID: 11230367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nitric oxide in the development of diabetic angiopathy.
    Santilli F; Cipollone F; Mezzetti A; Chiarelli F
    Horm Metab Res; 2004 May; 36(5):319-35. PubMed ID: 15156413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
    Sugimoto H; Shikata K; Wada J; Horiuchi S; Makino H
    Diabetologia; 1999 Jul; 42(7):878-86. PubMed ID: 10440132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
    Casey RG; Joyce M; Roche-Nagle G; Chen G; Bouchier-Hayes D
    J Surg Res; 2005 Feb; 123(2):176-81. PubMed ID: 15680375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
    Koo JR; Vaziri ND
    Kidney Int; 2003 Jan; 63(1):195-201. PubMed ID: 12472783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide in the normal kidney and in patients with diabetic nephropathy.
    Tessari P
    J Nephrol; 2015 Jun; 28(3):257-68. PubMed ID: 25216787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
    Balakumar P; Chakkarwar VA; Krishan P; Singh M
    Biomed Pharmacother; 2009 Mar; 63(3):171-9. PubMed ID: 18823739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.
    Tanimoto M; Fan Q; Gohda T; Shike T; Makita Y; Tomino Y
    Metabolism; 2004 Nov; 53(11):1473-9. PubMed ID: 15536604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy.
    Boels MG; van Faassen EE; Avramut MC; van der Vlag J; van den Berg BM; Rabelink TJ
    PLoS One; 2017; 12(1):e0170065. PubMed ID: 28103268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy.
    Amore A; Cirina P; Conti G; Cerutti F; Bagheri N; Emancipator SN; Coppo R
    Nephrol Dial Transplant; 2004 Jan; 19(1):53-60. PubMed ID: 14671039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
    Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
    J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.